Edwin Rock
Chief Medical Officer at Glycomimetics Inc (CBIO) since September 2022
Edwin Rock has filed 8 insider reports with the SEC since September 2022, as chief Medical Officer at Glycomimetics Inc (CBIO). Edwin Rock made no open-market purchases or sales in the last 12 months. In the latest filing, on June 24, 2024, Edwin Rock bought 305,000 shares of Glycomimetics Inc (CBIO) for $78.8K at an average of $0.26.
- Filings
- 8
- Companies
- 1
- Bought on market
- $726K
- Sold on market
- None
Companies where Edwin Rock is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Medical Officersince September 2022 | 680,403 | $726K | $1.07 | $13.00+1115% | Jun 24, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 21, 2024+$78.8KCBIOChief Medical Officer Rock Edwin bought $78,824 worth of shares (305,000 units at $0.26), increasing direct ownership by 81% to 680,403 unitsForm 4Open-market purchase
- Jan 12, 2024CBIOSEC Form 4 filed by Rock EdwinForm 4Grant or award
- Sep 22, 2023+$90.3KCBIOSEC Form 4: Rock Edwin bought $90,256 worth of shares (65,403 units at $1.38), increasing direct ownership by 21% to 375,403 unitsForm 4Open-market purchase
- Jan 19, 2023CBIOSEC Form 4 filed by Rock EdwinForm 4Grant or award
- Dec 22, 2022+$248KCBIOSEC Form 4: Rock Edwin bought $247,500 worth of shares (110,000 units at $2.25), increasing direct ownership by 55% to 310,000 unitsForm 4Open-market purchase
- Nov 15, 2022+$309KCBIOSEC Form 4: Rock Edwin bought $309,000 worth of shares (200,000 units at $1.54)Form 4Open-market purchase
- Sep 2, 2022CBIOSEC Form 4 filed by Rock EdwinForm 4Grant or award
- Sep 2, 2022CBIOSEC Form 3: New insider Rock Edwin claimed no ownership of stock in the companyForm 3New insider
Compare Edwin Rock with
- Edwin Rock vs Jan Pinkas1 shared
- Edwin Rock vs Ellie Eunkyung Im1 shared
- Edwin Rock vs Ryan Lynch1 shared
- Edwin Rock vs Richard William Scalzo1 shared
- Edwin Rock vs Jonathan McNeill1 shared
- Edwin Rock vs Barbara Harlin Bispham1 shared
Other insiders at the same companies
- Ryan LynchCBIO
- Ellie Eunkyung ImCBIO
- Jan PinkasCBIO
- Joshua T BrummCBIO
- Jonathan McNeillCBIO
- Richard William ScalzoCBIO
- Barbara Harlin BisphamCBIO
- Fairmount Funds Management LLCCBIO
- Jonathan ViolinCBIO
- David Charles LubnerCBIO
- Alexandra BalcomCBIO
- Susan MoranCBIO
- Christopher Grant DoughtyCBIO
- Bvf Partners L P/ilCBIO
Questions about Edwin Rock
- What is Edwin Rock's role at Glycomimetics Inc?
- Edwin Rock reports to the SEC as chief Medical Officer at Glycomimetics Inc (CBIO), according to the latest filing on June 24, 2024.
- How many shares does Edwin Rock own?
- After the latest filing that states it, Edwin Rock directly owned 680,403 shares of Glycomimetics Inc (CBIO). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Edwin Rock bought or sold stock recently?
- The most recent open-market purchase was on June 21, 2024: bought 305,000 shares of Glycomimetics Inc (CBIO) for $78.8K at an average of $0.26.
- How do I get alerts when Edwin Rock files?
- Follow Edwin Rock on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Edwin Rock (SEC CIK 0001945417). Totals count each trade once, skipping amendments whose original is on file, from Sep 7, 2022 on. View on SEC EDGAR · Get this as JSON